Vanguard Group
DPLO

Vanguard Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Vanguard Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,316,604
Closed -$29.3M – 4125
2019
Q4 		$29.3M Buy
7,316,604
+1,495,333
+26% +$7.02M ﹤0.01% 2345
2019
Q3 		$28.5M Buy
5,821,271
+113,166
+2% +$633K ﹤0.01% 2308
2019
Q2 		$34.8M Buy
5,708,105
+185,431
+3% +$986K ﹤0.01% 2281
2019
Q1 		$32.1M Sell
5,522,674
-131,645
-2% -$1.36M ﹤0.01% 2291
2018
Q4 		$76.1M Buy
5,654,319
+192,604
+4% +$3.25M ﹤0.01% 1818
2018
Q3 		$106M Buy
5,461,715
+209,939
+4% +$4.47M ﹤0.01% 1772
2018
Q2 		$134M Buy
5,251,776
+536,901
+11% +$12.5M 0.01% 1624
2018
Q1 		$95M Buy
4,714,875
+243,217
+5% +$5.67M ﹤0.01% 1739
2017
Q4 		$89.7M Buy
4,471,658
+178,191
+4% +$3.5M ﹤0.01% 1779
2017
Q3 		$88.9M Buy
4,293,467
+216,322
+5% +$3.66M ﹤0.01% 1774
2017
Q2 		$60.3M Buy
4,077,145
+210,334
+5% +$3.51M ﹤0.01% 1927
2017
Q1 		$61.7M Buy
3,866,811
+481,710
+14% +$6.95M ﹤0.01% 1904
2016
Q4 		$42.7M Sell
3,385,101
-131,823
-4% -$2.46M ﹤0.01% 2056
2016
Q3 		$98.5M Buy
3,516,924
+182,914
+5% +$6.14M 0.01% 1567
2016
Q2 		$117M Buy
3,334,010
+289,571
+10% +$9.1M 0.01% 1415
2016
Q1 		$83.4M Buy
3,044,439
+349,353
+13% +$10.3M 0.01% 1596
2015
Q4 		$92.2M Buy
2,695,086
+316,722
+13% +$9.88M 0.01% 1526
2015
Q3 		$68.3M Buy
2,378,364
+359,993
+18% +$15.4M ﹤0.01% 1700
2015
Q2 		$90.3M Buy
2,018,371
+740,931
+58% +$27.9M 0.01% 1591
2015
Q1 		$44.2M Buy
1,277,440
+610,840
+92% +$16.6M ﹤0.01% 1973
2014
Q4 		$18.2M Buy
+666,600
New +$16.2M ﹤0.01% 2269

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Vanguard Group's DPLO Position: Q1 2020 in Review

Vanguard Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 7,316,604 shares — an estimated $29.3M sold.

Vanguard Group first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $134M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Vanguard Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Vanguard Group sold 7,316,604 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $29.3M.
  • Vanguard Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
  • Vanguard Group's DIPLOMAT PHARMACY, INC. position peaked at $134M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Vanguard Group's 13F filing for Q1 2020, filed 15 May 2020.